<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.4: Address Root Causes (A): Infections and Toxins</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE theme for Root Causes/Infections */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #eff6ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #3b82f6;
        }

        .term-item .term {
            font-weight: 700;
            color: #1e3a8a;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        /* Paragraphs */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        /* Highlights */
        .highlight {
            background: linear-gradient(180deg, transparent 60%, #FFF59D 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        .patient-avatar {
            width: 55px;
            height: 55px;
            background: linear-gradient(135deg, #3b82f6, #1e3a8a);
            border-radius: 50%;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 24px;
            flex-shrink: 0;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 40px;
            border-radius: 16px;
            margin: 35px 0;
            position: relative;
            overflow: hidden;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(140px, 1fr));
            gap: 25px;
            text-align: center;
        }

        .stat-number {
            font-size: 42px;
            font-weight: 700;
            margin-bottom: 8px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Comparison Table */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
        }

        .data-table th {
            background: #f1f5f9;
            padding: 15px;
            text-align: left;
            font-weight: 600;
            color: #1e3a8a;
            border-bottom: 2px solid #e2e8f0;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-family: inherit;
        }

        .answer-text {
            display: none;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            margin-top: 15px;
            color: #1e3a8a;
        }

        .answer-text.show {
            display: block;
        }

        /* Footer and References */
        .references-box {
            background: #f9fafb;
            padding: 30px;
            border-radius: 14px;
            margin-top: 40px;
            font-size: 14px;
            border: 1px solid #eee;
        }

        .references-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        .takeaways-box {
            background: #f0fdf4;
            border-left: 5px solid #10b981;
            padding: 25px;
            margin: 40px 0;
            border-radius: 0 12px 12px 0;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            border-top: 1px solid #eee;
        }

        @media (max-width: 600px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: The C.A.L.M. Deep Dive</p>
            <h1 class="lesson-title">Lesson 8.4: Address Root Causes (A): Infections and Toxins</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Lesson 4 of 4</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#stealth"><span class="section-num">1</span>Stealth Pathogens & Autoimmunity</a></li>
                <li><a href="#bystander"><span class="section-num">2</span>The Mechanics of Bystander Activation</a></li>
                <li><a href="#biotoxins"><span class="section-num">3</span>Mycotoxins and CIRS</a></li>
                <li><a href="#detox"><span class="section-num">4</span>Optimizing Detoxification Pathways</a></li>
                <li><a href="#testing"><span class="section-num">5</span>Interpreting Laboratory Panels</a></li>
                <li><a href="#protocol"><span class="section-num">6</span>Clinical Application in C.A.L.M.</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the role of Epstein-Barr Virus (EBV) and Lyme disease as primary autoimmune triggers.</li>
                <li>Differentiate between molecular mimicry and bystander activation in tissue damage.</li>
                <li>Identify the clinical presentation of Chronic Inflammatory Response Syndrome (CIRS) related to mold.</li>
                <li>Explain the biochemical requirements for Phase I, II, and III liver detoxification.</li>
                <li>Develop a strategic approach to interpreting infectious and environmental toxin lab markers.</li>
            </ul>
        </div>

        <p>In the previous lesson, we explored the <span class="highlight">Gut-Immune Axis</span> and the role of intestinal permeability as a gateway to pathology. However, even with a perfectly sealed gut, a client may remain in a state of chronic flare if the "biological and chemical load" remains high. This lesson focuses on the "A" of the C.A.L.M. Autoimmune Protocolâ„¢: <span class="highlight">Addressing Root Causes</span> through the lens of stealth infections and environmental toxins.</p>

        <h2 id="stealth">1. Stealth Pathogens: The Hidden Drivers</h2>
        <p>A stealth pathogen is a microorganism (virus, bacteria, or parasite) that employs sophisticated strategies to evade the host immune system, often persisting in a latent or "smoldering" state for decades. In the context of autoimmunity, these pathogens act as the "environmental trigger" that meets "genetic susceptibility."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <div class="stat-number">32x</div>
                    <div class="stat-label">Higher MS Risk with EBV</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">99%</div>
                    <div class="stat-label">SLE Patients EBV+</div>
                </div>
                <div class="stat-item">
                    <div class="stat-number">45%</div>
                    <div class="stat-label">Lyme/Autoimmune Overlap</div>
                </div>
            </div>
        </div>

        <p>The most clinically significant stealth pathogens include:</p>
        <ul>
            <li><strong>Epstein-Barr Virus (EBV):</strong> Associated with Multiple Sclerosis (MS), Systemic Lupus Erythematosus (SLE), and Hashimotoâ€™s Thyroiditis. EBV can "immortalize" B-cells, leading to continuous autoantibody production.</li>
            <li><strong>Borrelia burgdorferi (Lyme Disease):</strong> Known for its ability to change surface proteins, confusing the immune system and triggering chronic joint or neurological inflammation.</li>
            <li><strong>Cytomegalovirus (CMV):</strong> Often implicated in Type 1 Diabetes and vasculitis due to its high affinity for endothelial cells.</li>
        </ul>

        <h2 id="bystander">2. The Mechanics of Bystander Activation</h2>
        <p>While we frequently discuss <span class="highlight">molecular mimicry</span> (where a pathogen looks like host tissue), <span class="highlight">bystander activation</span> is equally destructive. This occurs when the immune response to an infection is so robust that it causes collateral damage to surrounding healthy cells.</p>
        
        <p>During a localized infection, immune cells release pro-inflammatory cytokines (IL-1, IL-6, TNF-alpha) and reactive oxygen species (ROS) to kill the invader. If the infection is persistent, this "chemical warfare" damages the host cells. These damaged cells then release "danger signals" (DAMPs), which further activate the immune system, potentially leading to a loss of self-tolerance.</p>

        <div class="key-terms-box">
            <p class="box-label">Key Concept: The Hit-and-Run Theory</p>
            <div class="terms-grid">
                <div class="term-item">
                    <p class="term">Hit-and-Run</p>
                    <p class="definition">The theory that a virus initiates an autoimmune process and then disappears or goes latent, leaving the immune system in a permanent state of self-attack even after the initial trigger is gone.</p>
                </div>
            </div>
        </div>

        <h2 id="biotoxins">3. Biotoxins, Mycotoxins, and CIRS</h2>
        <p>Environmental toxins are not just "chemicals"; they include biological toxins produced by living organisms, most notably <span class="highlight">mycotoxins</span> from indoor water-damaged buildings. Chronic Inflammatory Response Syndrome (CIRS) is a multi-system, multi-symptom illness characterized by a genetic inability to clear these toxins.</p>

        <p>In individuals with specific <span class="highlight">HLA-DR/DQ</span> genetic haplotypes (roughly 25% of the population), the immune system fails to recognize biotoxins as "foreign." Instead of being cleared by antibodies, these toxins remain in circulation, binding to toll-like receptors and causing a "cytokine storm" that never ends. This is a primary driver of Fibromyalgia, Chronic Fatigue Syndrome, and various autoimmune presentations.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Toxin Category</th>
                        <th>Common Sources</th>
                        <th>Autoimmune Association</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Ochratoxin A</strong></td>
                        <td>Water-damaged buildings, contaminated grain</td>
                        <td>Nephropathy, Oxidative stress in B-cells</td>
                    </tr>
                    <tr>
                        <td><strong>Aflatoxin</strong></td>
                        <td>Peanuts, corn, damp storage</td>
                        <td>Suppression of T-regulatory cells</td>
                    </tr>
                    <tr>
                        <td><strong>Glyphosate</strong></td>
                        <td>Conventional agriculture</td>
                        <td>Intestinal permeability, loss of self-tolerance</td>
                    </tr>
                    <tr>
                        <td><strong>Heavy Metals</strong></td>
                        <td>Amalgam fillings, large fish, industrial air</td>
                        <td>Molecular mimicry in Thyroid (Hashimoto's)</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="detox">4. Optimizing Detoxification Pathways</h2>
        <p>In the C.A.L.M. Protocolâ„¢, we never "detox" a client in an active flare. We first <span class="highlight">Contain Inflammation</span>. Once stable, we must ensure the "drainage pathways" are open before mobilizing toxins. Mobilizing toxins in a client with a "clogged" system leads to the dreaded Herxheimer reaction.</p>

        <div class="principle-card">
            <div class="principle-title">The Three Phases of Detoxification</div>
            <p class="principle-text">Effective root-cause resolution requires all three phases to be synchronized:</p>
            <ul>
                <li><strong>Phase I (Bioactivation):</strong> Cytochrome P450 enzymes convert fat-soluble toxins into intermediate metabolites. *Requires: B-vitamins, Glutathione.*</li>
                <li><strong>Phase II (Conjugation):</strong> These intermediates are neutralized by adding a molecule (e.g., methyl, sulfur, or glucuronic acid). *Requires: Amino acids, NAC, Sulforaphane.*</li>
                <li><strong>Phase III (Excretion):</strong> The neutralized toxins are transported out of cells into bile or urine for elimination. *Requires: Proper hydration, fiber, and bile flow.*</li>
            </ul>
        </div>

        <h2 id="testing">5. Interpreting Laboratory Panels</h2>
        <p>As an Autoimmune Specialist, you must look beyond "Normal" ranges. We look for <span class="highlight">Optimal</span> ranges and patterns of reactivation.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Brain Fog" Breakthrough</p>
                    <p style="color:white; font-size:12px; margin:0;">Client: Sarah, 38 | Presentation: Sjogrenâ€™s & Fatigue</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div class="patient-avatar">S</div>
                    <div class="patient-info">
                        <h4>Sarah M.</h4>
                        <p>History of "recurrent mono" and living in a humid basement apartment.</p>
                    </div>
                </div>
                <p><strong>Initial Labs:</strong> EBV VCA IgG was >600 (very high), but IgM was negative. Conventional doctors said the infection was "past." Sarah's C-Reactive Protein (CRP) was 4.2 mg/L.</p>
                <p><strong>Advanced Testing:</strong> Urine Mycotoxin panel showed elevated <i>Ochratoxin A</i> and <i>Mycophenolic Acid</i>. EBV Early Antigen (EA) was positive, indicating <strong>active viral replication</strong> (reactivation).</p>
                <p><strong>Intervention:</strong> Sarah was moved to a mold-free environment, started on binders (activated charcoal/clay), and high-dose liposomal Vitamin C and Monolaurin for viral support.</p>
                <p><strong>Outcome:</strong> Within 4 months, her CRP dropped to 0.8 mg/L, and her Sjogren's markers (Anti-SSA) decreased by 30%. Her "brain fog" resolved completely.</p>
            </div>
        </div>

        <h2 id="protocol">6. Clinical Application in C.A.L.M.</h2>
        <p>When addressing root causes (A), follow this sequence to avoid exacerbating the client's condition:</p>
        <ol>
            <li><strong>Identify:</strong> Use PCR testing for viruses and urine panels for mycotoxins.</li>
            <li><strong>Remove:</strong> If the source is environmental (mold in home), the client <i>must</i> leave or remediate. You cannot supplement your way out of a toxic environment.</li>
            <li><strong>Open Drainage:</strong> Ensure the client is having 1-2 bowel movements daily and sweating (if tolerated).</li>
            <li><strong>Bind:</strong> Use sequestering agents (binders) to prevent the enterohepatic recirculation of toxins.</li>
            <li><strong>Support:</strong> Use targeted botanicals (e.g., Cat's Claw for Lyme, Olive Leaf for EBV) only after the toxic load is reduced.</li>
        </ol>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">Why might a client with "past" EBV (negative IgM) still be experiencing EBV-driven autoimmunity?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Negative IgM only rules out a primary (new) infection. EBV Early Antigen (EA) or high titers of VCA IgG often indicate "chronic reactivation," where the virus is active enough to trigger the immune system but not enough to trigger a standard IgM response.</div>
            </div>

            <div class="question-item">
                <p class="question-text">What is the primary danger of starting a "heavy metal detox" before fixing intestinal permeability?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">If the gut is "leaky," toxins mobilized from the tissues and excreted into the bile can be reabsorbed through the intestinal wall (enterohepatic recirculation), leading to systemic toxicity and a severe autoimmune flare.</div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Pathogen Persistence:</strong> Stealth infections like EBV and Borrelia use molecular mimicry and bystander activation to sustain chronic autoimmunity.</li>
                <li><strong>CIRS:</strong> Mold toxicity is often a genetic "blind spot" where the immune system cannot clear biotoxins, leading to permanent systemic inflammation.</li>
                <li><strong>Sequence Matters:</strong> Always open drainage pathways (Phase III) before inducing detoxification (Phase I & II).</li>
                <li><strong>Advanced Testing:</strong> Standard lab ranges are insufficient; look for Early Antigen (EA) for viruses and specific mycotoxin markers.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>Bittel et al. (2022). "Epstein-Barr Virus and the Pathogenesis of Multiple Sclerosis." <i>Science</i>.</li>
                <li>Shoemaker et al. (2018). "Chronic Inflammatory Response Syndrome: Diagnosis and Treatment." <i>Journal of Environmental and Public Health</i>.</li>
                <li>Vojdani et al. (2021). "Environmental Triggers of Autoimmune Diseases." <i>Frontiers in Immunology</i>.</li>
                <li>Lustig et al. (2023). "The Impact of Mycotoxins on the Gut-Immune Axis." <i>Toxins Journal</i>.</li>
                <li>Robinson et al. (2022). "Molecular Mimicry in the Drive of Autoimmunity." <i>Nature Reviews Rheumatology</i>.</li>
                <li>Genuis et al. (2020). "Toxicant Exposure and Autoimmune Disease: A Review." <i>Clinical Reviews in Allergy & Immunology</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Autoimmune Specialist Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>